Orion cancels its Annual General Meeting on Wednesday 25 March 2020 and postpones it to a later date

NEXT STORY
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Provides a Corporate Update
PREV STORY
ARECOR EXTENDS MULTI-PRODUCT COLLABORATION WITH CLINICAL STAGE BIOTECH
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2021 Financial Results on November 4, 2021

author_avatar
NASDAQ Market News

ERBA Diagnostics to Commence Trading on OTC Markets’ Pink Open Market After Delisting by the NYSE MKT

MIAMI, Sept. 30, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (the “Company”), a fully ...

author_avatar
NASDAQ Market News

SCYNEXIS Announces Successful Completion of Phase 1 Trial Evaluating Intravenous (IV) Formulation of Ibrexafungerp

author_avatar
NASDAQ Market News